This timely and meticulously research-based book pulls back the curtain on the systemic failures of the US pharmaceutical and healthcare industries, which have left millions struggling to afford life-saving medications.
A Crisis That Hits Close to Home
Did you know that the United States accounts for nearly 50% of global pharmaceutical revenues because its citizens pay the highest drug prices in the world? Each year, thousands of Americans die because they cannot afford essential medications like insulin, and millions more are forced to ration their care. In their groundbreaking work, Wencker and Orliac played a role as a spotlight on these grim realities while offering actionable solutions that could revolutionize the way Americans access and afford their medications. Also, while crafting this book, they planned to move with instituting a constitutional right to healthcare at state levels, as Oregon recently did, which could enable them to negotiate in a much more potent position. In the second part of their plan, they desired to import prices, rather than drugs, from our northern neighbor.
The Problem: Greed Meets Complicity
The book vividly describes the two central players driving the drug pricing crisis: Big Pharma and Pharmacy Benefit Managers (PBMs). From “patent thickets” and pay-for-delay deals to PBMs' opaque rebate schemes, the authors detail how these entities work in tandem to inflate prices, restrict access, and prioritize profits over people.
Through eye-opening examples, Solving the US Drug Conundrum reveals the stark contrasts between the US and European healthcare systems, where countries like France, Germany, and the UK provide affordable, high-quality drugs by leveraging transparent pricing models and stringent regulations.
The Solution: Bold Reforms Rooted in Common Sense
Unlike many proposals that rely on technological fixes, the book emphasizes practical reforms grounded in political integrity and common sense. Wencker and Orliac propose actionable steps, including:
Tightening patent laws to prevent monopolistic practices.
Adopting European-style drug assessment and pricing systems.
Enhancing transparency in PBM operations to curb hidden costs.
Leveraging public research funding to make medications more accessible.
Empowering employers and patients with strategies to navigate the current system effectively.
A Call to Action for Change
The authors go beyond diagnosis to inspire hope, arguing that meaningful reform is possible if Americans demand accountability from policymakers and corporate leaders. The book’s appendix includes a must-read guide for employers on reducing healthcare costs and improving employee access to affordable treatments.
Why This Book Matters Now
With healthcare reform high on the national agenda, Solving the US Drug Conundrum arrives at a pivotal moment. As Americans face rising costs and declining outcomes, this book equips readers with the knowledge and tools to advocate for a system that prioritizes patients over profits.
About the Author:
André Wencker
André Wencker, co-founder and CEO of Care2care International LLC, helps Americans access affordable pharmacy benefits. With an MS from HEC Paris and an Executive Public Health MBA, he has extensive experience in health insurance and served as treasurer for the French health research foundation FORCE.
Pascal Orliac
Pascal Orliac, co-founder and CMO of Care2care International LLC, helps Americans access affordable pharmacy benefits. He has held global HR executive roles in the USA and Europe and has lectured in management at the University of New Hampshire’s Paul College. Pascal holds an MBA from HEC Paris.
Book Name: SOLVING THE US DRUG CONUNDRUM
Author Name: ANDRE WENCKER & PASCAL ORLIAC
ISBN Number: 1917613636
Kindle Version: Click Here
Paperback Version: Click Here
Media Contact
Company Name: American Publishers Inc
Email: Send Email
Phone: +1(818)483-1118
Address:12100 Wilshire Boulevard, 8th Floor
City: Los Angeles
State: CA 90025
Country: United States
Website: https://americanpublishersinc.com/
